Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 6/30/2012 | 3/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -7.6% | -14.7% | 0.4% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.9% | 47.8% | 31.5% | 36.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5% | -1.3% | -11.4% | -23% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.6% | -13.9% | -21.9% | -33.3% |
| EPS | -0.011 | -0.01 | -0.02 | -0.02 |
| % Growth | -5% | 50% | 0% | – |
| EPS Diluted | -0.011 | -0.01 | -0.02 | -0.02 |
| Weighted Avg Shares Out | 15 | 15 | 15 | 15 |
| Weighted Avg Shares Out Dil | 15 | 15 | 15 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -0.7% | 2.9% | -7.6% | -19.1% |